Literature DB >> 11803102

Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958-1996.

Kari Hemminki1, Xinjun Li, Pauli Vaittinen.   

Abstract

OBJECTIVES: We wanted to examine reasons for the different incidence trends for cervical squamous cell carcinoma (SCC, declining) and adenocarcinoma (increasing).
METHODS: The Swedish Family-Cancer Database on 9.6 million individuals was used to derive incidence trends between 1958 and 1996. Cervical cancers were compared to vaginal and vulvar cancers.
RESULTS: A total of 15405 invasive cervical SCCs and 1920 adenocarcinomas were identified. The incidence of SCCs decreased and that of adenocarcinoma increased during the study period, with similar trends among the in situ forms. The incidence of in situ vaginal and vulvar SCC increase 22-fold, whereas, invasive SCC and adenocarcinoma remained unchanged. The age-incidence curves for adenocarcinoma resembled those for SCC before screening, suggesting similar clinical course.
CONCLUSIONS: The data suggest that the increase in the incidence of adenocarcinoma is related to an increasing prevalence of human papilloma virus (HPV) infection in female genitals, perhaps in addition to other factors. The increase is not seen in SCC because of effective screening.

Entities:  

Mesh:

Year:  2002        PMID: 11803102     DOI: 10.1016/s0301-2115(01)00508-5

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  11 in total

Review 1.  Endocervical glandular lesions: controversial aspects and ancillary techniques.

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2003-03       Impact factor: 3.411

2.  Human papillomavirus bowel colonization in inflammatory bowel disease: A comparative case control study.

Authors:  Mahmoud H Mosli; Marwan Albeshri; Mohammad N Alsanea; Turki AlAmeel; Haneen Alabsi; Majid Alsahafi; Omar Saadah; Yousef Qari
Journal:  J Family Med Prim Care       Date:  2022-05-14

Review 3.  Cervical cancer screening.

Authors:  Dorothy J Wiley; Bradley J Monk; Emmanuel Masongsong; Kristina Morgan
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

4.  Evaluation of 'see-see and treat' strategy and role of HIV on cervical cancer prevention in Uganda.

Authors:  Twaha Mutyaba; Florence Mirembe; Sven Sandin; Elisabete Weiderpass
Journal:  Reprod Health       Date:  2010-05-10       Impact factor: 3.223

5.  Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study.

Authors:  Pankaj Deka; Debabrata Barmon; Sushrata Shribastava; Amal Chandra Kataki; J D Sharma; M Bhattacharyya
Journal:  J Midlife Health       Date:  2014-01

6.  Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type.

Authors:  Maria Persson; K Miriam Elfström; Sven-Erik Olsson; Joakim Dillner; Sonia Andersson
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

7.  Detection of human papillomavirus infection by molecular tests and its relation to colonic polyps and colorectal cancer.

Authors:  Faten Gazzaz; Mahmoud H Mosli; Hani Jawa; Abdulrahman Sibiany
Journal:  Saudi Med J       Date:  2016-03       Impact factor: 1.484

8.  Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands.

Authors:  Mirte Scherpenisse; Madelief Mollers; Rutger M Schepp; Hein J Boot; Chris J L M Meijer; Guy A M Berbers; Fiona R M van der Klis; Hester E de Melker
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

9.  Prognostic value of histopathology and trends in cervical cancer: a SEER population study.

Authors:  Vincent Vinh-Hung; Claire Bourgain; Georges Vlastos; Gábor Cserni; Mark De Ridder; Guy Storme; Anne-Thérèse Vlastos
Journal:  BMC Cancer       Date:  2007-08-23       Impact factor: 4.430

10.  Triage of HR-HPV positive women with minor cytological abnormalities: a comparison of mRNA testing, HPV DNA testing, and repeat cytology using a 4-year follow-up of a population-based study.

Authors:  Maria Persson; K Miriam Elfström; Sophia Brismar Wendel; Elisabete Weiderpass; Sonia Andersson
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.